Excessive adiposity, metabolic health, and risks for genital human papillomavirus infection in adult women: a population-based cross-sectional study

Table 4 Results of multivariable Poisson regression on any- or high risk-type HPV prevalence by adiposity and metabolic health status, fasting adult women aged 20–59 (N = 1972^a) in NHANES 2003–2010

	Any-HPV				HR-HPV
	aPR^b	95 % CI			aPR^b	95 % CI
	aPR^b	LL	UL	p-value	aPR^b	LL	UL	p-value
WHtR > 0.6	0.97	0.86	1.08	0.542	0.82	0.66	1.02	0.074
Obesity (BMI ≥ 30 kg/m²)	0.96	0.85	1.09	0.534	0.77	0.62	0.95	0.016
Central obesity (WC >88 cm)	0.96	0.86	1.08	0.502	0.89	0.72	1.09	0.254
MetS	0.98	0.84	1.14	0.760	0.85	0.68	1.08	0.176
Metabolic health and obesity
Normal	1.00				1.00
MUNO	1.06	0.83	1.36	0.625	1.19	0.88	1.62	0.263
MHO	1.00	0.84	1.19	0.971	0.86	0.68	1.09	0.204
MetS & obese	0.94	0.80	1.11	0.478	0.69	0.51	0.94	0.018

aPR adjusted prevalence ratio, BMI body mass index, CI confidence interval, LL lower limit, MetS metabolic syndrome by ATP III criteria, MHO metabolically healthy and obese, MUNO metabolically unhealthy and non-obese, UL upper limit, WC waist circumference, WHtR waist-to-height ratio
^aFifteen out of 1987 women had missing formation about either number of lifetime partners or health insurance coverage
^bAdjusting for survey cycle, age, race/ethnicity, college degree or not, marital status, health insurance coverage or not, and lifetime sexual exposure

ISSN: 2052-9538